Duke-developed immunotherapy for brain tumors heads to clinical trial
Duke researchers are leading a phase I clinical trial to evaluate a new experimental treatment for glioblastoma, one of the most aggressive and deadly forms of brain cancer. The drug is a type of immunotherapy known as a Brain Bispecific T-cell Engager (BRiTE), which is designed to cross the blood-brain barrier and to help the patient’s own immune cells (T-cells) recognize and attack cancer cells.
Study links gut bacteria to poor growth in preterm infants
A team led by Duke neonatologist Noelle Younge, MD, MHS, has found evidence that the intestinal microbiome plays a direct role in slow weight gain and poor growth in preterm infants.
Richard P. Shannon, MD: Giving to build a better future for patients
A nationally recognized leader in quality and safety, Richard P. Shannon, MD, and his family's support of the Duke Health Patient Care Fund reflects their belief that even small acts of generosity can have a lasting impact, helping Duke Health respond to immediate patient needs while advancing innovation and enhancing care for patients and families.
DCRI to Lead National Consortium to Advance Safe, Scalable AI for Heart Failure Care
This story was originally published on the DCRI website
First Remote-Controlled Device for Male Incontinence in U.S. Implanted at Duke
A surgical team at Duke Health has performed the first U.S. implantation of a new remote-controlled artificial urinary sphincter that aims to give men who struggle with incontinence after treatment for pelvic cancers a more personalized and discreet way to manage bladder control.
David Tuveson to join Duke Health as executive director of the Duke Cancer Institute
David Tuveson, MD, PhD, will join Duke Health as executive director of the Duke Cancer Institute (DCI), effective October 31, 2026. Tuveson, a preeminent cancer biologist, is currently the Roy J. Zuckerberg Professor of Cancer Research and director of the National Cancer Institute-Designated Cancer Center at Cold Spring Harbor Laboratory. He is also the chief scientist for the Lustgarten Foundation for Pancreatic Cancer Research.
The next frontier of heart care
Duke is building the tools to catch heart disease before patients know they have it.
Rajagopal named director of the Duke Physician-Scientist Strong Start Award Program
Sudarshan Rajagopal, MD, PhD, has been named the new director of the Duke Physician-Scientist Strong Start Award Program, a flagship initiative funded by the Nanaline H. Duke Foundation that supports the development of early-career physician-scientists as they transition to independent research careers.
The door to cold
When you feel toothpaste's minty tingle, it's caused by the opening of a molecular "door" found in sensory nerve cells in your mouth.